Finerenone. Mineralocorticoid receptor (MR) antagonist, Treatment of chronic kidney disease/diabetic nephropathy, Treatment of heart failure
Year: 2015
Type: article
Source: Drugs of the Future
Author: Cole, P.
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4361022900